These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds. Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322 [TBL] [Abstract][Full Text] [Related]
4. A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters. Kraft TE; Heitmeier MR; Putanko M; Edwards RL; Ilagan MX; Payne MA; Autry JM; Thomas DD; Odom AR; Hruz PW Antimicrob Agents Chemother; 2016 Dec; 60(12):7407-7414. PubMed ID: 27736766 [TBL] [Abstract][Full Text] [Related]
5. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target. Joet T; Eckstein-Ludwig U; Morin C; Krishna S Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024 [TBL] [Abstract][Full Text] [Related]
6. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria]. Ellekvist P; Colding H Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884 [TBL] [Abstract][Full Text] [Related]
7. Hexose-monophosphate shunt activity in intact Plasmodium falciparum-infected erythrocytes and in free parasites. Atamna H; Pascarmona G; Ginsburg H Mol Biochem Parasitol; 1994 Sep; 67(1):79-89. PubMed ID: 7838186 [TBL] [Abstract][Full Text] [Related]
8. Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy. Moles E; Urbán P; Jiménez-Díaz MB; Viera-Morilla S; Angulo-Barturen I; Busquets MA; Fernàndez-Busquets X J Control Release; 2015 Jul; 210():217-29. PubMed ID: 26008752 [TBL] [Abstract][Full Text] [Related]
9. Efflux of 6-deoxy-D-glucose from Plasmodium falciparum-infected erythrocytes via two saturable carriers. Goodyer ID; Hayes DJ; Eisenthal R Mol Biochem Parasitol; 1997 Feb; 84(2):229-39. PubMed ID: 9084042 [TBL] [Abstract][Full Text] [Related]
10. The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir. Kraft TE; Armstrong C; Heitmeier MR; Odom AR; Hruz PW Antimicrob Agents Chemother; 2015 Oct; 59(10):6203-9. PubMed ID: 26248369 [TBL] [Abstract][Full Text] [Related]
11. The hexose transporter of Plasmodium falciparum is a worthy drug target. Joët T; Krishna S Acta Trop; 2004 Feb; 89(3):371-4. PubMed ID: 14744563 [TBL] [Abstract][Full Text] [Related]
12. Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality. Slavic K; Straschil U; Reininger L; Doerig C; Morin C; Tewari R; Krishna S Mol Microbiol; 2010 Mar; 75(6):1402-13. PubMed ID: 20132450 [TBL] [Abstract][Full Text] [Related]
13. Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering. Heitmeier MR; Hresko RC; Edwards RL; Prinsen MJ; Ilagan MXG; Odom John AR; Hruz PW PLoS One; 2019; 14(5):e0216457. PubMed ID: 31071153 [TBL] [Abstract][Full Text] [Related]
14. Why is the Plasmodium falciparum hexose transporter a promising new drug target? Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822 [TBL] [Abstract][Full Text] [Related]
15. Glycolysis in Plasmodium falciparum results in modulation of host enzyme activities. Mehta M; Sonawat HM; Sharma S J Vector Borne Dis; 2006 Sep; 43(3):95-103. PubMed ID: 17024857 [TBL] [Abstract][Full Text] [Related]